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In the bioethics literature, there has been considerable
debate as to whether giving heroin addicts legal access to
free heroin in connection with research on the effectiveness
of heroin prescription as a treatment alternative constitutes
a breach of ethical research standards. The ethical issue here
is that the researcher must obtain the informed consent of
the study participants. For their consent to be valid,
individuals must give it voluntarily. The question is whether
consent can be said to have been given voluntarily if the
person has heroin addiction (we are assuming, of course,
that they are neither intoxicated nor experiencing with-
drawal symptoms at the time of giving consent). Those who
claim that it cannot argue that it is in the nature of heroin
addiction for individuals to lose their ability to resist their
desire for heroin. Since a loss of ability means heroin
addicts cannot refuse offers of free heroin, neither can we
presume that they can give voluntary consent to take part in
research that involves giving them a choice of free heroin.1
According to those who maintain that consent given by
heroin addicts can be valid, this argument is ﬂawed. Several
studies show that ﬁnancial concerns, fear of arrest, values
regarding parenthood and many other factors inﬂuencing
decisions in general often persuade a person addicted to
heroin to cease their drug-oriented behaviour.2 That heroin
addicts frequently respond to such incentives means that
they cannot have lost the ability to resist their desire for
heroin. We can presume, therefore, that heroin addicts have
the competence to give voluntary consent to take part in
trials involving the drug.
We want to argue that both sides in this debate are
mistaken. Although it is plausible that many - perhaps even
most or all - heroin addicts have the ability to resist their
desire to take heroin, the degree to which their consent is
voluntarily given greatly depends on the wider social and
psychological circumstances under which they choose
whether to consent or not. Focusing on these circumstances
rather than universal and hard-to-verify claims about
abilities of resistance allows for a more ﬂexible, case-to-
case approach, one that does not rule out the possibility that
while some heroin addicts might be competent to give
voluntary consent, some might not. One advantage of this
approach compared with the alternatives is that it provides
a safety net to minimise the risk of inﬂicting harm on the
individuals who participate in these kinds of studies.
Before presenting our argument, a note of caution is
in order: we do not want to claim that the answer to the
ethical question raised by research on heroin prescription
as a treatment alternative is alone sufﬁcient to determine
whether or not such research should be carried out. Even
if the issue of voluntary consent in heroin trials was
problematic, it does not follow that prescribing heroin as
a treatment alternative should necessarily be banned. If,
for example, the risks to the participants were small or
non-existent while the beneﬁts outweighed such risks,
strategies that circumvent the normal standards of consent
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should indeed be considered. One such strategy could be to
appoint some surrogate authority who is not involved in the
study (e.g. a family member) to ensure the best interests of
the participant, or perhaps to relax competence-deﬁning
criteria.1 Whether prescribing heroin therapeutically is an
effective way of treating heroin users needs to be
determined empirically and will not be discussed here.
Two concepts of ‘voluntariness’
What does it mean to say that a consent is voluntary? In the
bioethics literature it is widely agreed that a person acts
voluntarily if he or she wills the action (performs it
intentionally) without being under the controlling inﬂuence
of another person or condition.3 Controlling inﬂuences are
divided into ‘external’ and ‘internal’ depending on whether
they are caused by the intentional actions of other persons
(such as different forms of coercion or manipulation) or lack
of internal self-control, an incapacity typically associated
with mental illness. Although this characterisation of
voluntary action is both plausible and, no doubt, helpful
in many situations in which clinicians have to assess a
person’s capacity, we believe it is ill suited to explaining how
certain social circumstances and the beliefs they inform
might sometimes constrain choices. This is because the
circumstances and beliefs might exert a controlling
inﬂuence on the person, causing them to feel pressured
into performing certain actions (like enrolling in clinical
trials, for example), without necessarily removing their
internal capacity for self-control. In fact, we believe
research on the effectiveness of heroin prescription as a
treatment alternative provides an illustration of this, as we
try to show in this article. First, however, we need to
introduce another concept of ‘voluntariness’ that comes
from political and legal philosophy.4 This will allow us to
explain how social circumstances and the beliefs they
inform could deprive a person of their voluntariness
without removing their internal capacity for self-control.
We introduce it here with a view to suggesting an alternative
- and, we believe, important - perspective on the effects
addiction might be thought to have on the voluntariness of
heroin addicts’ consent that has been largely ignored in the
debate about this issue. It is worth noting that it relies on a
consequentialist ethical theory, which some readers may
have objections about. We cannot provide a full conceptual
defence of this notion or its ethical foundations here.
Consequentialism, however, is a widely used approach in
much ethical analysis in the ﬁeld of healthcare.
Very brieﬂy, this alternative concept of voluntariness
begins by distinguishing between three types of options in
terms of ‘acceptability’, where the standard for the
acceptability of options is an objective standard of well-
being. First, there are options that one strongly dislikes,
which one holds to be ‘unacceptable’ in the sense that they
bring one’s well-being below a certain threshold. These are
options that are thoroughly bad because they involve losses
it would be unreasonable to expect anyone to bear. Second,
there are options that are undesirable but not thoroughly
bad, which one holds to be ‘acceptable’ in the sense that
they bring one’s well-being above a certain threshold. These
are options that have sufﬁcient value to be choiceworthy.
Finally, there are options that bring one’s well-being up to a
high level and that one likes so much that one chooses
them. Consider then the following plausible deﬁnition of
voluntary choice: a choice is voluntary if it is not made
because no other acceptable alternative options are
available. This negative deﬁnition implies the existence of
two types of situations in which a person makes a voluntary
choice. First, there are situations in which she has at least
two acceptable options and chooses one of them because, all
things considered, she prefers one option to the other.
Second, there are situations in which she has at least one
option that she likes so much that she chooses it because of
that, whether or not there are any acceptable alternative
options. In neither of these cases is her reason for making
her choice not having other acceptable alternative options.
One implication of this concept of voluntariness is that
whether a choice is voluntary or not depends not just on the
person’s internal capacity for self-control, but crucially also
on her beliefs about her options and hence actual
motivation for making the choice. As we argue in the next
section, we cannot rule out that the social circumstances
typical of many chronic heroin addicts affect their beliefs
about their options in a way that undermine the
voluntariness of their consent even if they retain their
capacity for self-control (for an extended version of this
argument, see Henden, 2013).5
Why the circumstances of heroin addicts might
undermine the voluntary nature of their consent
To determine whether heroin addicts are able to give
voluntary consent, assuming the understanding of
voluntariness just outlined, we need to know something
about their beliefs about their options. Of course, one
difﬁculty is that heroin addicts are not all alike. Their
individual circumstances including social and personal
resources are likely to differ, and their beliefs about their
options are therefore likely to differ as well. That being said,
there is widespread consensus that heroin treatment is
suited to a minority of heroin users as a second-line
treatment for those individuals who do not respond to
methadone or buprenorphine treatment delivered under
optimal conditions.6 Thus, heroin trials have essentially
sought to determine the therapeutic value of prescribing
heroin to high-risk heroin users for whom such beneﬁts
cannot be expected or achieved by existing treatment
options.7 When discussing the competence of heroin addicts
to consent to participation in heroin trials we should
therefore focus primarily on chronic addicts with a history
of repeated treatment failure. The prevalence of health
and social problems in this group of addicts is widely
acknowledged.7 Major psychopathological studies of heroin
users report rates of comorbidity that far exceed those of
general population estimates. In addition to having high rates
of comorbidity, it is well known that many individuals with
chronic heroin addiction lead marginalised, impoverished
lives, often associated with criminal activity, anxiety and
high levels of risk. Can it be ruled out that such
circumstances might create situations of constrained
choice? We believe that it cannot. To see how such a
situation could arise, consider ﬁrst the option of obtaining
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heroin from the street. Many individuals reach a point in
their chronic heroin addiction history in which their
current lifestyles do not seem to them to be sustainable
any longer; evidence of this is that many eventually seek
help for their addiction. Presumably the costs of
maintaining this lifestyle begin to exceed the beneﬁts. Put
in the terminology introduced in the last section, we might
say that they come to consider a life centred on the
procurement of heroin to be ‘unacceptable’ in the sense of
no longer bringing their well-being above a certain
threshold. Consider next the option of abstaining from
heroin. For an action to be an acceptable option, it is not
sufﬁcient to have the ability or power to perform it. One
must also believe one has that ability or power. There are
many studies showing that mood disorders such as
depression and anxiety lower belief in the person’s
capabilities or perceived self-efﬁcacy.8 Since there is a
strong correlation between mood disorders and chronic
heroin addiction, it is reasonable to assume that many
heroin addicts harbour a low sense of self-efﬁcacy and lack
conﬁdence in their ability to abstain from heroin.9 Chronic
heroin addiction is associated with hopelessness about the
future and a sense of powerlessness to inﬂuence the
direction one’s life is going - reinforced by a history of
failed attempts to abstain. Now, a lack of belief in one’s own
ability is clearly detrimental to one’s will. Thus, according to
a standard philosophical view, intentions involve plans of
action and such plans, in order to be rational, require the
belief that one has an acceptable chance of changing the
world in ways one believes are for the better.10 Given this
view, it would not be rational to form intentions one
believes one is not going to carry out. The implication is that
individuals with heroin addiction who have little belief in
their capacity to abstain are likely to ﬁnd it extremely
difﬁcult to form the intention to abstain. That is, since they
believe they are going to fail if they try, they are likely to
lack the will to abstain. Consequently, their commitment to
changing their way of life may be low. Since believing one
has reasons not to make an effort to exercise an ability
(since one thinks it is futile) is not equivalent to lacking the
ability, the problem here is not a lack of ability. The problem
rather is an impairment of rational will due to a lack of
belief in self-efﬁcacy. It cannot be ruled out that such
impairments of the will may lead some chronic heroin
addicts to falsely believe abstinence is a non-option.
If this is correct, everything depends on the option of
taking part in research. Will a person with chronic heroin
addiction consider this option to have a high value, not just
as an acceptable way of avoiding the hassle on the street or
to get free heroin from a legal source, but as a way of
improving their well-being so much that they choose it
because of that? In fact, there appears to be little reason to
think so. Many heroin addicts actually refuse to take part in
these studies. In heroin trials in Switzerland, only a third of
participants decided to take part when given the choice.11
One reason, presumably, is that they ﬁnd the costs of
keeping regular appointments with healthcare professionals
too high. Chronic heroin addicts who do consent must judge
these costs as less important than the beneﬁts associated
with obtaining free heroin. Presumably, they consider the
value of obtaining free heroin to be sufﬁcient to make
participation in research acceptable, even if they do not
consider the combined value of obtaining free heroin and
taking part in research to be very high.
To sum up, it cannot be ruled out that many chronic
heroin addicts for whom the problems of procuring the drug
on the street are unacceptable, but for whom abstinence is
not an option, believe they have only one option, which is to
consent to research involving the medical provision of
heroin. Since there is evidence to suggest that they might
choose this option not because they like it very much, but
because they have no acceptable alternative options, their
consent could be construed as non-voluntary. What
constrains their choice is not their desire for heroin, but
the wider social and psychological circumstances of their
heroin addiction and the beliefs about the options these
circumstances create.
Our reasoning here is, of course, hypothetical. We have
no empirical evidence of the contents of the decision-
making processes in individuals with heroin addiction (nor
do we know whether any such evidence exists). However, if
it is a plausible reconstruction of what these processes
might look like given the situational constraints and our
current state of knowledge, it sufﬁces, we believe, for our
current purpose, to provide a reason why we should not take
the voluntariness of their consent for granted.
Voluntary consent and risk-minimising
ethical analysis
As we have argued, given a certain plausible conception of
voluntariness, we cannot rule out that the beliefs held by
individuals with heroin addiction about their options and
hence their motivation for action might undermine the
voluntariness of their consent even if they have the ability
to resist their desire for heroin. One important reason for
this is that the wider social circumstances typical of many
such individuals may shape their beliefs about their capacity
to make choices (such as making abstinence seem
impossible) and these beliefs (which may be false) could
then impair their will to abstain from heroin use.
This suggests that paying special attention to these
circumstances should form an integral part of the
assessment of whether or not the person’s consent is
voluntary. However, the argument may perhaps strike some
as overly philosophical. On what basis can we decide
between different conceptions of voluntariness? Let us
end with some more general considerations in favour of the
view we have presented.
According to the World Medical Association’s declaration
on ethical principles for medical research involving human
subjects (the Helsinki Declaration), the participation of
human subjects in research requires the voluntary consent
of individuals who are considered competent to give their
consent (www.wma.net/en/30publications/10policies/b3/).
What makes it so ethically challenging to assess whether,
in the case of heroin research, a person is competent to give
their consent voluntarily is, of course, that we have no
uncontroversial concept of voluntariness that applies to the
speciﬁc circumstances of heroin addicts, and we have no
direct access to the mental processes of the consenting
individual to accurately appraise whatever conception we
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lean towards. This means that judgements about voluntary
consent will always involve uncertainty. How can we best
deal with this uncertainty? An ethical way of justifying why
one approach is chosen over another might be to compare
the potential harm these approaches may inﬂict on the
research participants. Such an overall account of harm will
have to reﬂect the inherent uncertainty of the assessment
and also include considerations of harm potentially caused
by a ﬂawed assessment.
In this article we have identiﬁed three different
approaches to consent in individuals with heroin addiction:
(a) a person’s desire for heroin rules out any ability to
choose freely between receiving heroin or not, hence
we should presume that no heroin addict can voluntarily
consent to medically prescribed heroin;
(b) heroin addicts have the ability to choose freely
between receiving heroin or not, hence we should
presume that all heroin addicts can voluntarily
consent to medically prescribed heroin;
(c) the social and psychological circumstances of some
individuals with heroin addiction might be such that
we cannot presume that they can voluntarily consent
to medically prescribed heroin.
Which of these approaches would minimise the harm
inﬂicted on the person if they were used to inform an
assessment of their competence to give voluntary consent?
Consider (a). There may be circumstances in which it
might be better for some individuals with heroin addiction
to receive free heroin under medical supervision than
getting it on the street. That is, the harm inﬂicted on these
addicts by obtaining heroin on the street might greatly
exceed the potential harm resulting from participation in
heroin trials, because of mistaken assumptions about valid
consent. Thus, these addicts might end up worse off than if
(a) had not been used as the basis for an assessment of
voluntary consent. Ironically, the protective safety net of
the ethical standard of valid consent breaks down in this
case, and in fact inﬂicts more harm than if the standard
were ignored. Next, consider (b). The circumstances of
many individuals addicted to heroin might suggest that they
have some chance of succeeding in abstinence-based drug
treatment programmes. However, this option of trying to
achieve a life free of heroin is effectively ruled out if they
receive heroin medication on a regular basis. Consequently,
the harm these individuals may suffer could be considerable
if their consent is accepted as valid without further
questioning. Again, they could end up worse off than if we
had not used (b) as the basis of the assessment of voluntary
consent. Finally, consider (c). This approach differs from (a)
and (b) by focusing on the particular person’s social and
psychological circumstances (including motivating beliefs)
as the basis of the assessment, rather than on universal and
hard-to-verify claims about abilities of resistance of persons
with heroin addiction. It therefore allows for a more
ﬂexible, case-to-case approach, one that neither rules out
competence to consent voluntarily nor rules it in. This
option would minimise the risk of inﬂicting more harm than
if (c) had not been applied. Consequently, the potential of
inﬂicting harm by assuming this approach is smaller
compared with (a) and (b).
Conclusion
Philosophy and medicine are inherent to mental healthcare.
Clinical assessments of mental non-observable categories
rely on adequate philosophical conceptualisations. Since
the adequacy of these conceptualisations cannot be settled
a priori and uncertainty will always be involved whenever
attempts are made to conﬁrm or reject their appropriateness
a posteriori, philosophy offers a means of identifying the
most apt conceptualisation according to a risk-minimising
ethical analysis. An assessment of capacity for voluntary
consent in individuals with heroin addiction should be
based on an approach that minimises the risk of harming
them more than if the approach were not applied. According
to our argument, focusing on addicts’ social and psychological
circumstances (including motivating beliefs) as the basis of
an assessment rather than their abilities of resistance is the
most apt approach in this regard. We therefore suggest that
this approach to the assessment of participant consent
should guide and inform an ethical practice of including and
excluding heroin addicts in research on heroin provision.
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